Beijing SL Pharmaceutical Co Ltd
SZSE:002038
Wall Street
Price Targets
Price Targets Summary
Beijing SL Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Beijing SL Pharmaceutical Co Ltd is 42.72 CNY .
Price Targets
Operating Income
Forecast
Operating Income Estimate
Beijing SL Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Beijing SL Pharmaceutical Co Ltd's operating income is -18%. The projected CAGR for the next 3 years is 87%.
Net Income
Forecast
Net Income Estimate
Beijing SL Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Beijing SL Pharmaceutical Co Ltd's net income is -13%. The projected CAGR for the next 3 years is 13%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Beijing SL Pharmaceutical Co Ltd's stock price target?
Price Target
42.72
CNY
According to Wall Street analysts, the average 1-year price target for Beijing SL Pharmaceutical Co Ltd is 42.72 CNY .
What is Beijing SL Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
14%
For the last 8 years the compound annual growth rate for Beijing SL Pharmaceutical Co Ltd's revenue is -2%. The projected CAGR for the next 3 years is 14%.
What is Beijing SL Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
87%
For the last 8 years the compound annual growth rate for Beijing SL Pharmaceutical Co Ltd's operating income is -18%. The projected CAGR for the next 3 years is 87%.
What is Beijing SL Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
13%
For the last 8 years the compound annual growth rate for Beijing SL Pharmaceutical Co Ltd's net income is -13%. The projected CAGR for the next 3 years is 13%.
You don't have any saved screeners yet
